Generating new prions by targeted mutation or segment duplication

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 28, 2015, Pages 8584-8589

  Paul, Kacy R ^a   Hendrich, Connor G ^a   Waechter, Aubrey ^a   Harman, Madison R ^a   Ross, Eric D ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Amyloid; Prion; Sup35; Yeast

Indexed keywords

DNA; NITROGEN; OLIGOPEPTIDE; PRION PROTEIN; PRION;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE DUPLICATION; GENETIC VARIABILITY; MUTATION; NATURAL SELECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; YEAST; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; MOLECULAR GENETICS; PRION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; GENE DUPLICATION; MOLECULAR SEQUENCE DATA; MUTATION; PRIONS; SEQUENCE HOMOLOGY, AMINO ACID; YEASTS;

EID: 84937116663     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1501072112     Document Type: Article

References (43)

1. Sipe JD, Cohen AS (2000) Review: History of the amyloid fibril. J Struct Biol 130(2-3):88-98.
2. Kisilevsky R, Fraser PE (1997) A beta amyloidogenesis: Unique, or variation on a systemic theme? Crit Rev Biochem Mol Biol 32(5):361-404.
3. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216(4542):136-144.
4. Byers JS, Jarosz DF (2014) Pernicious pathogens or expedient elements of inheritance: The significance of yeast prions. PLoS Pathog 10(4):e1003992.
5. Fowler DM, Koulov AV, Balch WE, Kelly JW (2007) Functional amyloid - from bacteria to humans. Trends Biochem Sci 32(5):217-224.
6. Liebman SW, Chernoff YO (2012) Prions in yeast. Genetics 191(4):1041-1072.
7. Wickner RB, et al. (2015) Yeast prions: Structure, biology, and prion-handling systems. Microbiol Mol Biol Rev 79(1):1-17.
8. Wickner RB (1994) [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 264(5158):566-569.
9. Liu JJ, Sondheimer N, Lindquist SL (2002) Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci USA 99(Suppl 4):16446-16453.
10. Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN (1994) The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137(3):671-676.
11. Du Z (2011) The complexity and implications of yeast prion domains. Prion 5(4):311-316.
12. Cascarina SM, Ross ED (2014) Yeast prions and human prion-like proteins: Sequence features and prediction methods. Cell Mol Life Sci 71(11):2047-2063.
13. King OD, Gitler AD, Shorter J (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 1462:61-80.
14. Alberti S, Halfmann R, King O, Kapila A, Lindquist S (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137(1):146-158.
15. Toombs JA, McCarty BR, Ross ED (2010) Compositional determinants of prion formation in yeast. Mol Cell Biol 30(1):319-332.
16. Gonzalez Nelson AC, et al. (2014) Increasing prion propensity by hydrophobic insertion. PLoS ONE 9(2):e89286.
17. Ross ED, Maclea KS, Anderson C, Ben-Hur A (2013) A bioinformatics method for identifying Q/N-rich prion-like domains in proteins. Methods Mol Biol 1017:219-228.
18. Toombs JA, et al. (2012) De novo design of synthetic prion domains. Proc Natl Acad Sci USA 109(17):6519-6524.
19. Tartaglia GG, Pechmann S, Dobson CM, Vendruscolo M (2007) Life on the edge: A link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci 32(5):204-206.
20. Hosoda N, et al. (2003) Translation termination factor eRF3 mediates mRNA decay through the regulation of deadenylation. J Biol Chem 278(40):38287-38291.
21. Li X, Rayman JB, Kandel ER, Derkatch IL (2014) Functional role of Tia1/Pub1 and Sup35 prion domains: Directing protein synthesis machinery to the tubulin cytoskeleton. Mol Cell 55(2):305-318.
22. Shewmaker F, Mull L, Nakayashiki T, Masison DC, Wickner RB (2007) Ure2p function is enhanced by its prion domain in Saccharomyces cerevisiae. Genetics 176(3):1557-1565.
23. Toombs JA, Liss NM, Cobble KR, Ben-Musa Z, Ross ED (2011) [PSI+] maintenance is dependent on the composition, not primary sequence, of the oligopeptide repeat domain. PLoS ONE 6(7):e21953.
24. Wadsworth JD, Hill AF, Beck JA, Collinge J (2003) Molecular and clinical classification of human prion disease. Br Med Bull 66:241-254.
25. Liu JJ, Lindquist S (1999) Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature 400(6744):573-576.
26. Parham SN, Resende CG, Tuite MF (2001) Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J 20(9):2111-2119.
27. Kajava AV (2012) Tandem repeats in proteins: From sequence to structure. J Struct Biol 179(3):279-288.
28. Katti MV, Sami-Subbu R, Ranjekar PK, Gupta VS (2000) Amino acid repeat patterns in protein sequences: Their diversity and structural-functional implications. Protein Sci 9(6):1203-1209.
29. Halfmann R, et al. (2011) Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins. Mol Cell 43(1):72-84.
30. DePace AH, Santoso A, Hillner P, Weissman JS (1998) A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93(7):1241-1252.
31. Doel SM, McCready SJ, Nierras CR, Cox BS (1994) The dominant PNM2-mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137(3):659-670.
32. Cox BS (1965) PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 20:505-521.
33. Kochneva-Pervukhova NV, Poznyakovski AI, Smirnov VN, Ter-Avanesyan MD (1998) C-terminal truncation of the Sup35 protein increases the frequency of de novo generation of a prion-based [PSI+] determinant in Saccharomyces cerevisiae. Curr Genet 34(2):146-151.
34. Tuite MF, Mundy CR, Cox BS (1981) Agents that cause a high frequency of genetic change from [psi+] to [psi-] in Saccharomyces cerevisiae. Genetics 98(4):691-711.
35. Ferreira PC, Ness F, Edwards SR, Cox BS, Tuite MF (2001) The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 40(6):1357-1369.
36. Jung G, Masison DC (2001) Guanidine hydrochloride inhibits Hsp104 activity in vivo: A possible explanation for its effect in curing yeast prions. Curr Microbiol 43(1):7-10.
37. Ross ED, Edskes HK, Terry MJ, Wickner RB (2005) Primary sequence independence for prion formation. Proc Natl Acad Sci USA 102(36):12825-12830.
38. Ellegren H (2000) Microsatellite mutations in the germline: Implications for evolutionary inference. Trends Genet 16(12):551-558.
39. Stankiewicz P, Lupski JR (2010) Structural variation in the human genome and its role in disease. Annu Rev Med 61:437-455.
40. Tank EM, Harris DA, Desai AA, True HL (2007) Prion protein repeat expansion results in increased aggregation and reveals phenotypic variability. Mol Cell Biol 27(15):5445-5455.
41. MacLea KS, Ross ED (2011) Strategies for identifying new prions in yeast. Prion 5(4):263-268.
42. Derkatch IL, Bradley ME, Hong JY, Liebman SW (2001) Prions affect the appearance of other prions: The story of [PIN(+)]. Cell 106(2):171-182.
43. Sherman F (1991) Getting started with yeast. Methods Enzymol 194:3-21.